524717 Stock Overview
Engages in the manufacture and sale of biological products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Titan Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹458.70 |
| 52 Week High | ₹1,017.85 |
| 52 Week Low | ₹423.00 |
| Beta | 0.59 |
| 1 Month Change | 3.40% |
| 3 Month Change | -41.34% |
| 1 Year Change | -1.78% |
| 3 Year Change | 59.44% |
| 5 Year Change | 1,267.21% |
| Change since IPO | 2,427.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524717 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 6.2% | 1.1% | 1.3% |
| 1Y | -1.8% | 2.6% | 3.0% |
Return vs Industry: 524717 underperformed the Indian Chemicals industry which returned 2.6% over the past year.
Return vs Market: 524717 underperformed the Indian Market which returned 3% over the past year.
Price Volatility
| 524717 volatility | |
|---|---|
| 524717 Average Weekly Movement | 10.1% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.6% |
Stable Share Price: 524717's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524717's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 449 | Naresh Singla | titanbiotechltd.com |
Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, peptone, OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer yeast protein; and animal nutrition comprising mannan oligosaccharide, amino chelated mineral, sodium and calcium butyrate, sodium and calcium propionate, protein hydrolysate, and active dry yeast.
Titan Biotech Limited Fundamentals Summary
| 524717 fundamental statistics | |
|---|---|
| Market cap | ₹3.63b |
| Earnings (TTM) | ₹224.81m |
| Revenue (TTM) | ₹1.61b |
16.9x
P/E Ratio2.4x
P/S RatioIs 524717 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524717 income statement (TTM) | |
|---|---|
| Revenue | ₹1.61b |
| Cost of Revenue | ₹772.31m |
| Gross Profit | ₹839.69m |
| Other Expenses | ₹614.88m |
| Earnings | ₹224.81m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.20 |
| Gross Margin | 52.09% |
| Net Profit Margin | 13.95% |
| Debt/Equity Ratio | 1.8% |
How did 524717 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield7%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/19 11:33 |
| End of Day Share Price | 2025/03/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Titan Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.